Genpharmasec share news and announcements

BSE: 531592Commercial Services & SuppliesSmall Cap

₹0.99₹0.03 (2.94%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹1.02.

52-week range of traded prices to 23 Oct 2026

₹0.75Low, 30 Mar 2026₹1.84High, 27 Oct 2025

Market cap: ₹55 Cr3,222nd largest listed
P/E: Earlier quarters restated in the year
P/B: 0.8
Dividend yield: Nonein the last 12 months
ROCE: −1.4%
Debt to equity: 0.50
Volume, BSE: 4,22,891

Genpharmasec share news and announcements

609 announcements, routine notices left out, newest first. Page 2 of 13.

May 2025
- 21 May · Board meeting
  Outcome of the Meeting of Board of Directors held on Wednesday, May 21, 2025. (opens in a new tab)
- 13 May · Board meeting
  Meeting on 21 May 2025: audited results
- 13 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 21/05/2025 ,inter alia, to consider and approve 1. To consider, approve & take .... (opens in a new tab)
Mar 2025
- 24 Mar · Board meeting
  Outcome of the Separate Meeting of Independent Directors of the Company Held on Monday, March 24, 2025. (opens in a new tab)
- 19 Mar · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 24/03/2025 ,inter alia, to consider and approve 1. To Review the performance of .... (opens in a new tab)
Feb 2025
- 10 Feb · Business
  Statement of deviation or Variation in the use of proceeds of Rights Issue for the Quarter ended 31st December, 2024. (opens in a new tab)
- 10 Feb · Results
  Submission of Integrated Filing for the quarter and nine months ended December 31, 2024. (opens in a new tab)
- 10 Feb · Results
  Unaudited Standalone & Consolidated Financial Result for the quarter and nine months ended December 31, 2024. (opens in a new tab)
- 10 Feb · Results
  Outcome of the Meeting of Board of Directors held on Monday, February 10, 2025. (opens in a new tab)
- 3 Feb · Board meeting
  Meeting on 10 Feb 2025: quarterly results
- 3 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 10/02/2025 ,inter alia, to consider and approve 1. To consider and approve Unaudited .... (opens in a new tab)
Dec 2024
- 10 Dec · Business
  Press Release regarding recent agreement with Amneal Healthcare Private Limited. (opens in a new tab)
Nov 2024
- 12 Nov · Business
  Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 30th September, 2024. (opens in a new tab)
- 12 Nov · Results
  Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended September 30, 2024. (opens in a new tab)
- 12 Nov · Results
  Outcome of the Meeting of Board of Directors held on Tuesday, November 12, 2024. (opens in a new tab)
- 5 Nov · Board meeting
  Meeting on 12 Nov 2024: quarterly results
- 5 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve 1. To consider and approve Un-audited .... (opens in a new tab)
Aug 2024
- 13 Aug · Business
  Statement of Deviation or Variation in the use of the proceeds of Rights issue for the Quarter ended 30th June, 2024. (opens in a new tab)
- 13 Aug · Results
  Unaudited Standalone & Consolidated Financial Results of the company for the quarter ended 30th June, 2024. (opens in a new tab)
- 13 Aug · Board meeting
  Outcome of the Meeting of Board of Directors held on Tuesday, August 13, 2024. (opens in a new tab)
- 6 Aug · Board meeting
  Meeting on 13 Aug 2024: quarterly results
- 5 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve 1. To consider and approve Un-Audited .... (opens in a new tab)
Jul 2024
- 23 Jul · Meeting
  Disclosure of Voting Result and Scrutinizers Report of the 32nd Annual General Meeting of the Company held on 23rd July 2024 at 11.00 A.M. (opens in a new tab)
- 23 Jul · Meeting
  Proceedings of the 32nd Annual General Meeting of the Members of the Company held on Tuesday 23rd July, 2024 at 11.00 A.M. (opens in a new tab)
- 1 Jul · Reg. 34 (1) Annual Report.
  Annual Report for Financial Year 2023-2024. (opens in a new tab)
- 1 Jul · Meeting
  Notice of 32nd Annual General Meeting to be held on July 23, 2024. (opens in a new tab)
Jun 2024
- 27 Jun · Meeting
  Intimation of Book closure for the Annual General Meeting to be held on 23rd July, 2024. (opens in a new tab)
- 27 Jun · Board meeting
  Outcome of the Meeting of Board of Directors held on Thursday, 27th June, 2024 at 02:30 P.M. (opens in a new tab)
- 24 Jun · Board meeting
  Meeting on 27 Jun 2024: annual general meeting
- 24 Jun · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 27/06/2024 ,inter alia, to consider and approve 1.To Fix the Day, Date, Time and .... (opens in a new tab)
May 2024
- 30 May · Business
  Statement of deviation or variation in the use of proceeds of Rights issue for the quarter ended 31st March, 2024. (opens in a new tab)
- 24 May · Results
  Audited Standalone & Consolidated Financial Results of the company for the quarter and financial year ended 31st March 2024. (opens in a new tab)
- 24 May · Board meeting
  Outcome of the Meeting of Board of Directors held on Friday, May 24, 2024 at 03.00 P.M. (opens in a new tab)
- 14 May · Board meeting
  Meeting on 24 May 2024: audited results
- 14 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 24/05/2024 ,inter alia, to consider and approve 1. The Audited Standalone & Consolidated .... (opens in a new tab)
- 14 May · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
  Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars .... (opens in a new tab)
Apr 2024
- 26 Apr · Management
  Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 for Appointment of Whole Time Director of the company. (opens in a new tab)
- 24 Apr · Submission Of Compliance Certificate Under Regulation 40(9) And 40(10) Of SEBI (LODR), 2015 For The Year Ended On March 31, 2024.
  In compliance with the regulation 40(9) and 40(10) of the SEBI(LODR) Regulation, 2015 please find enclosed herewith compliance certificate issued by Mr. Jaymin Modi, Practicing company .... (opens in a new tab)
- 8 Apr · Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulation, 2015 For The Year Ended 31St March, 2024.
  Compliance Certificate for the year ended 31st March, 2024. (opens in a new tab)
- 1 Apr · Business
  Update on acquisition of 70% stake in Derren Healthcare private Limited (opens in a new tab)
Mar 2024
- 27 Mar · Management
  Pursuant to Reg. 30 of SEBI (LODR) Reg. 2015, we wish to inform you that Mr. Hardik Makwana is appointed as the Company Secretary and Compliance Officer of the Company w.e.f. 27th March, 2024. (opens in a new tab)
- 26 Mar · Board meeting
  Outcome of the Separate Meeting of Independent Directors of the company held on Tuesday, March 26, 2024. (opens in a new tab)
- 21 Mar · Board meeting
  Meeting on 27 Mar 2024
- 21 Mar · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 27/03/2024 ,inter alia, to consider and approve 1. To consider and take on record .... (opens in a new tab)
- 20 Mar · Management
  Pursuant to Reg. 30 of SEBI (LODR) Reg. 2015, this is to inform you that Ms. Heta Shah, Company Secretary and Compliance Officer of Genpharmasec limited has tendered her resignation vide .... (opens in a new tab)
- 20 Mar · Board meeting
  Meeting on 26 Mar 2024
- 20 Mar · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 26/03/2024 ,inter alia, to consider and approve 1. To Review the performance of .... (opens in a new tab)
- 12 Mar · Management
  This is to inform you that, Mr. Ulhas Deosthale, the Whole Time Director of the Company is resigning from the post of executive Director w.e.f 12th March, 2024 as due to his pre-occupation .... (opens in a new tab)
- 11 Mar · Business
  Update on Aquisition under Reg. 30 of SEBI(LODR)Reg. 2015. along with filing of the enclosed as Annexure A. (opens in a new tab)
Feb 2024
- 29 Feb · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yogeshkumar Rasiklal Sanghavi (opens in a new tab)

Genpharmasec share news and announcements

May 2025

Mar 2025

Feb 2025

Dec 2024

Nov 2024

Aug 2024

Jul 2024

Jun 2024

May 2024

Apr 2024

Mar 2024

Feb 2024